Cancer Chemoprevention and Nutri-Epigenetics: State of the Art and Future Challenges
The DOI matches its Crossref record; 287 of the 287 references it cites were found in a registry or an index.
Abstract
The term "epigenetics" refers to modifications in gene expression caused by heritable, but potentially reversible, changes in DNA methylation and chromatin structure. Epigenetic alterations have been identified as promising new targets for cancer prevention strategies as they occur early during carcinogenesis and represent potentially initiating events for cancer development. Over the past few years, nutriepigenetics - the influence of dietary components on mechanisms influencing the epigenome - has emerged as an exciting new field in current epigenetic research. During carcinogenesis, major cellular functions and pathways, including drug metabolism, cell cycle regulation, potential to repair DNA damage or to induce apoptosis, response to inflammatory stimuli, cell signalling, and cell growth control and differentiation become deregulated. Recent evidence now indicates that epigenetic alterations contribute to these cellular defects, for example epigenetic silencing of detoxifying enzymes, tumor suppressor genes, cell cycle regulators, apoptosis-inducing and DNA repair genes, nuclear receptors, signal transducers and transcription factors by promoter methylation, and modifications of histones and non-histone proteins such as p53, NF-κB, and the chaperone HSP90 by acetylation or methylation.The present review will summarize the potential of natural chemopreventive agents to counteract these cancer-related epigenetic alterations by influencing the activity or expression of DNA methyltransferases and histone modifying enzymes. Chemopreventive agents that target the epigenome include micronutrients (folate, retinoic acid, and selenium compounds), butyrate, polyphenols from green tea, apples, coffee, black raspberries, and other dietary sources, genistein and soy isoflavones, curcumin, resveratrol, dihydrocoumarin, nordihydroguaiaretic acid (NDGA), lycopene, anacardic acid, garcinol, constituents of Allium species and cruciferous vegetables, including indol-3-carbinol (I3C), diindolylmethane (DIM), sulforaphane, phenylethyl isothiocyanate (PEITC), phenylhexyl isothiocyanate (PHI), diallyldisulfide (DADS) and its metabolite allyl mercaptan (AM), cambinol, and relatively unexplored modulators of histone lysine methylation (chaetocin, polyamine analogs). So far, data are still mainly derived from in vitro investigations, and results of animal models or human intervention studies are limited that demonstrate the functional relevance of epigenetic mechanisms for health promoting or cancer preventive efficacy of natural products. Also, most studies have focused on single candidate genes or mechanisms. With the emergence of novel technologies such as next-generation sequencing, future research has the potential to explore nutriepigenomics at a genome-wide level to understand better the importance of epigenetic mechanisms for gene regulation in cancer chemoprevention.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There are many bioactive molecules present in food and herbs, in addition to folate, that are capable of influencing epigenetics and that have been touted as potential chemopreventative agents. Examples include various B vitamins, retinoic acid, vitamin D3, reservatrol, genistein and daidzein, epigallocatechin-3-gallate (EGCG), and curcumin (Gerhauser, 2013; Stefanska et al., 2012).”
From Influence of Metabolism on Epigenetics and Disease (2013) · cites this paper as Gerhauser, 2013
Citations
Cites
3 retracted
Kikuno, N., Shiina, H., Urakami, S., Kawamoto, K., Hirata, H., Tanaka, Y., Majid, S., Igawa, M., & Dahiya, R. (2008) · International Journal of Cancer · doi:10.1002/ijc.23590 · Cited by 219 · cited 1×
“H3K9 hyperacetylation could be associated with reduced expression and nuclear localization of SIRT1 after genistein treatment [154].”
BackgroundRetractedBalasubramanian, S., Adhikary, G., & Eckert, R. L. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp314 · Cited by 142 · cited 2×
“Recent research indicates that EGCG may regulate expression of cell cycle regulators p21 and p27 and apoptotic proteins by influencing polycomb group (PcG)-mediated histone modifications [184].”
BackgroundRetractedPrasad, S., Ravindran, J., Sung, B., Pandey, M. K., & Aggarwal, B. B. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-1113 · Cited by 79 · cited 1×
“Similar to the activities of anacardic acid, garcinol reduced the expression of various NF-kB target proteins, including anti-apoptotic survivin, Bcl-2, XIAP, and cFLIP [265].”
RetractedHallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590 · cited 1×
“Various genes affecting cell cycle progression have been identified as tumor suppressor genes, first of all p53 and pRB [212].”
BackgroundHanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399 · cited 3×
“mediators [256].”
BackgroundChromatin modifications and their function
Kouzarides, T. (2007) · Cell · doi:10.1016/j.cell.2007.02.005 · Cited by 10,883
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321 · cited 1×
“p21, also known as CDK-interacting protein 1 (Cip1) or wild-type p53-activated fragment 1 (WAF1), is encoded by the cyclin-dependent kinase inhibitor 1 CDKN1A gene locus [221–223].”
BackgroundMicroRNA signatures in human cancers
Calin, G. A., & Croce, C. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1997 · Cited by 7,590 · cited 1×
“apoptosis, and proliferation, and are known to be altered in a variety of chronic degenerative diseases including cancer [201].”
BackgroundJaenisch, R., & Bird, A. (2003) · Nature Genetics · doi:10.1038/ng1089 · Cited by 6,325 · cited 10×
“A p ig en in C el er y , ch am o m il e D N M T i [3 7 ]”
BackgroundResultInfluentialThe phosphatidylinositol 3-Kinase–AKT pathway in human cancer
Vivanco, I., & Sawyers, C. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc839 · Cited by 6,056 · cited 3×
“The tumor suppressor PTEN (phosphatase and tensin homolog deleted on chromosome 10) negatively regulates the phosphatidylinositol 3-kinase (PI3K)-AKT pathway that transmits anti-apoptotic survival signals and regulates cell proliferation, growth and motility [245].”
BackgroundRegulation of chromatin by histone modifications
Bannister, A. J., & Kouzarides, T. (2011) · Cell Research · doi:10.1038/cr.2011.22 · Cited by 6,012 · cited 4×
“Subgroups include the GNAT (hGCN5, PCAF), MYST (MYST, Tip60), p300/CBP (p300/CBP), SRC (SRC-1), and TAFII250 families (TAFII250) [119, 190].”
BackgroundInfluentialThe p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651 · cited 1×
“p21, also known as CDK-interacting protein 1 (Cip1) or wild-type p53-activated fragment 1 (WAF1), is encoded by the cyclin-dependent kinase inhibitor 1 CDKN1A gene locus [221–223].”
BackgroundJones, P. A., & Baylin, S. B. (2007) · Cell · doi:10.1016/j.cell.2007.01.029 · Cited by 4,515 · cited 2×
“Increased methylation (DNA hypermethylation) of promoter CGIs leads to transcriptional silencing of tumor suppressors and other genes with important biological functions [12, 16, 17].”
BackgroundSmall molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan
Howitz, K. T., Bitterman, K. J., Cohen, H. Y., Lamming, D. W., Lavu, S., Wood, J. G., Zipkin, R. E., Chung, P., Kisielewski, A., Zhang, L.-L., et al. (2003) · Nature · doi:10.1038/nature01960 · Cited by 3,796
Epigenetic differences arise during the lifetime of monozygotic twins
Fraga, M. F., Ballestar, E., Paz, M. F., Ropero, S., Setien, F., Ballestar, M. L., Heine-Suñer, D., Cigudosa, J. C., Urioste, M., Benitez, J., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500398102 · Cited by 3,602 · cited 1×
“) [3, 9] as has been exemplified in studies with monozygotic twins and inbred animals [10, 11].”
ResultNuclear factor-κB in cancer development and progression
Karin, M. (2006) · Nature · doi:10.1038/nature04870 · Cited by 3,519
Review article: the role of butyrate on colonic function
HAMER, H. M., JONKERS, D., VENEMA, K., VANHOUTVIN, S., TROOST, F. J., & BRUMMER, R. ‐. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03562.x · Cited by 2,721 · cited 1×
“Since dietary fiber consumption has been associated with colon cancer prevention [231], Archer C.”
Backgroundp21 in cancer: Intricate networks and multiple activities
Abbas, T., & Dutta, A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2657 · Cited by 2,712
Many roads to maturity: microRNA biogenesis pathways and their regulation
Winter, J., Jung, S., Keller, S., Gregory, R. I., & Diederichs, S. (2009) · Nature Cell Biology · doi:10.1038/ncb0309-228 · Cited by 2,656 · cited 1×
“MiRNAs are generated from RNA precursor structures by a protein complex system composed of members of the Argonaute protein family, polymerase II-dependent transcription, and the ribonucleases Drosha and Dicer [202].”
BackgroundThe development of androgen-independent prostate cancer.
Feldman, B. J., & Feldman, D. (2001) · Nature reviews. Cancer · doi:10.1038/35094009 · Cited by 2,326 · cited 1×
“sensitive target genes, resulting in increased proliferation and survival [267].”
BackgroundCancer epigenomics: DNA methylomes and histone-modification maps
Esteller, M. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2005 · Cited by 2,146 · cited 2×
“Increased methylation (DNA hypermethylation) of promoter CGIs leads to transcriptional silencing of tumor suppressors and other genes with important biological functions [12, 16, 17].”
BackgroundA gene hypermethylation profile of human cancer.
Esteller, M., Corn, P. G., Baylin, S. B., & Herman, J. G. (2001) · PubMed · Cited by 2,032
Molecular targets of dietary agents for prevention and therapy of cancer
Aggarwal, B. B., & Shishodia, S. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.02.009 · Cited by 1,754 · cited 1×
“NF-kB has been extensively studied as a target for chemopreventive agents [263].”
BackgroundWnt signalling and its impact on development and cancer
Klaus, A., & Birchmeier, W. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2389 · Cited by 1,595 · cited 3×
“disrupted, and b-catenin is stabilized, accumulates in the cytosol, and finally translocates to the nucleus, where it interacts with Tcf/Lef and activates the transcription of Wnt target genes, including c-Myc, cyclin D1 and many others [274].”
BackgroundInfluentialActivation of Transcription Factor NF-κB Is Suppressed by Curcumin (Diferuloylmethane)
Singh, S., & Aggarwal, B. B. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.42.24995 · Cited by 1,386
Overview of cell death signaling pathways
Jin, Z., & El-Deiry, W. S. (2005) · Cancer Biology & Therapy · doi:10.4161/cbt.4.2.1508 · Cited by 1,326 · cited 1×
“Bax is a member of the Bcl-2 protein family of apoptosis regulators which play an important role in mediating the intrinsic, mitochondrial pathway of apoptosis induction [232, 233].”
BackgroundPrinciples for modulation of the nuclear receptor superfamily
Gronemeyer, H., Gustafsson, J.-Å., & Laudet, V. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1551 · Cited by 1,226 · cited 2×
“RXR heterodimerization with RARs or other steroid hormone receptors allows fine-tuning of nuclear hormone receptor signaling [277].”
BackgroundDuration of Nuclear NF-κB Action Regulated by Reversible Acetylation
Chen, L.-F., Fischle, W., Verdin, E., & Greene, W. C. (2001) · Science · doi:10.1126/science.1062374 · Cited by 1,222 · cited 1×
“Reversible acetylation at lysine 310 mediated by the HAT p300 is required for full trans-activating activity [260–262].”
BackgroundFang, M., Wang, Y., Ai, N., Hou, Z., Sun, Y., Lu, H., Welsh, W. J., & Yang, C. S. (2003) · PubMed · Cited by 1,201
Kunnumakkara, A. B., Anand, P., & Aggarwal, B. B. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.009 · Cited by 1,073 · cited 1×
“Curcumin (diferuloyl methane) is a well characterized cancer chemopreventive agent derived from turmeric (Curcuma longa) [211].”
BackgroundCruciferous vegetables and human cancer risk: epidemiologic evidence and mechanistic basis
HIGDON, J., DELAGE, B., WILLIAMS, D., & DASHWOOD, R. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2007.01.009 · Cited by 1,039 · cited 1×
“Under low gastric pH conditions I3C is condensed to polycyclic compounds such as DIM as the major condensation product [237].”
BackgroundSodium butyrate inhibits histone deacetylation in cultured cells
Candido, E. (1978) · Cell · doi:10.1016/0092-8674(78)90305-7 · Cited by 1,036 · cited 1×
“Initial work focused on its anti-proliferative and differentiation-inducing effects in leukemia cell lines [228–230].”
BackgroundBelinsky, S. A., Nikula, K. J., Palmisano, W. A., Michels, R., Saccomanno, G., Gabrielson, E., Baylin, S. B., & Herman, J. G. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.20.11891 · Cited by 956 · cited 1×
“Hypermethylation of the p16 promoter is frequently observed in all major human malignancies, including hepatocellular carcinoma, primary gastric carcinoma, Barrett’s esophagus and esophageal adenocarcinoma [214], breast cancer [215], squamous cell carcinoma of the lung [216], colorectal cancer [217], lymphoma [218], a…”
BackgroundDolinoy, D. C., Weidman, J. R., Waterland, R. A., & Jirtle, R. L. (2006) · Environmental Health Perspectives · doi:10.1289/ehp.8700 · Cited by 934
The diverse and complex roles of NF-κB subunits in cancer
Perkins, N. D. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3204 · Cited by 852
The 5-methylcytosine content of DNA from human tumors
Gama-Sosa, M. A., Slagel, V. A., Trewyn, R. W., Oxenhandler, R., Kuo, K. C., Gehrke, C. W., & Ehrlich, M. (1983) · Nucleic Acids Research · doi:10.1093/nar/11.19.6883 · Cited by 844 · cited 1×
“In contrast, global loss of DNA methylation at repetitive genomic sequences (DNA hypomethylation) during carcinogenesis has been associated with genomic instability and chromosomal aberrations and was first described about 30 years ago [18, 19] (Fig.”
BackgroundHypomethylation of DNA from Benign and Malignant Human Colon Neoplasms
Goelz, S. E., Vogelstein, B., Hamilton, S. R., & Feinberg, A. P. (1985) · Science · doi:10.1126/science.2579435 · Cited by 840 · cited 1×
“In contrast, global loss of DNA methylation at repetitive genomic sequences (DNA hypomethylation) during carcinogenesis has been associated with genomic instability and chromosomal aberrations and was first described about 30 years ago [18, 19] (Fig.”
BackgroundBalasubramanyam, K., Varier, R. A., Altaf, M., Swaminathan, V., Siddappa, N. B., Ranga, U., & Kundu, T. K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409024200 · Cited by 832
Lost in Transcription: p21 Repression, Mechanisms, and Consequences
Gartel, A. L., & Radhakrishnan, S. K. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3995 · Cited by 818 · cited 2×
“Overexpression of p21 can lead to G1-phase, G2-phase, or S-phase arrest, whereas p21-deficient cells fail to undergo cell cycle arrest in response to p53 activation after DNA damage [225].”
BackgroundPTEN loss in the continuum of common cancers, rare syndromes and mouse models
Hollander, M. C., Blumenthal, G. M., & Dennis, P. A. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3037 · Cited by 794 · cited 2×
“PTEN / was shown to lead to early onset of prostate or mammary cancer in mouse models [245, 246].”
Backgroundn-Butyrate causes histone modification in HeLa and Friend erythroleukaemia cells
RIGGS, M. G., WHITTAKER, R. G., NEUMANN, J. R., & INGRAM, V. M. (1977) · Nature · doi:10.1038/268462a0 · Cited by 787 · cited 1×
“Initial work focused on its anti-proliferative and differentiation-inducing effects in leukemia cell lines [228–230].”
BackgroundDi Croce, L., Raker, V. A., Corsaro, M., Fazi, F., Fanelli, M., Faretta, M., Fuks, F., Coco, F. L., Kouzarides, T., Nervi, C., et al. (2002) · Science · doi:10.1126/science.1065173 · Cited by 787 · cited 1×
“Treatment of APL cells with ATRA reduced RARb2 promoter methylation linked with RARb2 mRNA reexpression [106].”
BackgroundSauve, A. A., Wolberger, C., Schramm, V. L., & Boeke, J. D. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.74.082803.133500 · Cited by 763 · cited 2×
“Class III is comprised of sirtuins 1–7, which are structurally unrelated to class I and II HDACs and require NAD as a cofactor for activity [191, 192].”
BackgroundMining the Wnt pathway for cancer therapeutics
Barker, N., & Clevers, H. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2154 · Cited by 743
Epigenetic gene silencing in cancer: the DNA hypermethylome
Esteller, M. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm018 · Cited by 725 · cited 1×
“RARb has been identified as silenced by promoter methylation in various tumor types, including colorectal, breast, prostate, head and neck, stomach, and liver cancer, and lymphoma (overview in [279]).”
BackgroundThe effect of sodium butyrate on histone modification
Sealy, L. (1978) · Cell · doi:10.1016/0092-8674(78)90306-9 · Cited by 686
Chen, D., Cui, Q. C., Yang, H., & Dou, Q. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2126 · Cited by 674 · cited 1×
“Disulfiram is an inhibitor of aldehyde dehydrogenase currently used clinically for the treatment of alcoholism [282], and has been shown to prevent chemically-induced carcinogenesis in various animal models.”
BackgroundAcetylation of non-histone proteins modulates cellular signalling at multiple levels
Spange, S., Wagner, T., Heinzel, T., & Krämer, O. H. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.08.027 · Cited by 664 · cited 1×
“As further outlined below, several important regulatory proteins and transcription factors such as p53, E2F, and nuclear factor-kB (NF-kB) involved in stress response, inflammation, and apoptosis have been shown to be regulated by acetylation [193–195].”
BackgroundA Novel CpG Island Set Identifies Tissue-Specific Methylation at Developmental Gene Loci
Illingworth, R., Kerr, A., DeSousa, D., Jørgensen, H., Ellis, P., Stalker, J., Jackson, D., Clee, C., Plumb, R., Rogers, J., et al. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060022 · Cited by 634
Aberrant Epigenetic Landscape in Cancer: How Cellular Identity Goes Awry
Berdasco, M., & Esteller, M. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.10.005 · Cited by 618 · cited 10×
“# ro m o te r m et h L eu k em ia p 3 p at h w ay [5 2 ]”
BackgroundInfluentialChemoprevention of colon cancer by calcium, vitamin D and folate: molecular mechanisms
Lamprecht, S. A., & Lipkin, M. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1144 · Cited by 583 · cited 2×
“Overall, the results are inconclusive and depend on various parameters, for example dose and timing of the intervention, the severity of folate deficiency, and health status (reviewed in [23, 66–68, 76]).”
BackgroundVerkerk, R., Schreiner, M., Krumbein, A., Ciska, E., Holst, B., Rowland, I., De Schrijver, R., Hansen, M., Gerhäuser, C., Mithen, R., et al. (2009) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200800065 · Cited by 569 · cited 2×
“Indole-3-carbinol (IC3) is the main hydrolysis product of the glucosinolate glucobrassicin [234].”
BackgroundBalasubramanyam, K., Altaf, M., Varier, R. A., Swaminathan, V., Ravindran, A., Sadhale, P. P., & Kundu, T. K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402839200 · Cited by 546
p21 WAF1 is required for butyrate-mediated growth inhibition of human colon cancer cells
Archer, S. Y., Meng, S., Shei, A., & Hodin, R. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.6791 · Cited by 535 · cited 1×
“established a link between butyrate-mediated HDAC inhibition, p21 induction, and cell growth inhibition in colon cancer cell lines [130].”
BackgroundIdentification of a specific inhibitor of the histone methyltransferase SU(VAR)3-9
Greiner, D., Bonaldi, T., Eskeland, R., Roemer, E., & Imhof, A. (2005) · Nature Chemical Biology · doi:10.1038/nchembio721 · Cited by 521
X Chromosome Dosage Compensation: How Mammals Keep the Balance
Payer, B., & Lee, J. T. (2008) · Annual Review of Genetics · doi:10.1146/annurev.genet.42.110807.091711 · Cited by 521 · cited 10×
“# ro m o te r m et h B re as t h E R T [6 2 ]”
BackgroundInfluentialSmall Molecule Modulators of Histone Acetyltransferase p300
Balasubramanyam, K., Swaminathan, V., Ranganathan, A., & Kundu, T. K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301580200 · Cited by 515 · cited 1×
“5 and 5 mM, respectively [124].”
Mechanisms for the Inhibition of DNA Methyltransferases by Tea Catechins and Bioflavonoids
Lee, W. J., Shim, J.-Y., & Zhu, B. T. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.008367 · Cited by 507 · cited 1×
“reported a slight reduction of RARb2 promoter methylation by EGCG intervention [44].”
BackgroundCancer chemoprevention by dietary polyphenols: Promising role for epigenetics
Link, A., Balaguer, F., & Goel, A. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.06.036 · Cited by 497
A Novel Mechanism of Chemoprotection by Sulforaphane
Myzak, M. C., Karplus, P. A., Chung, F.-L., & Dashwood, R. H. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1326 · Cited by 494 · cited 2×
“Consistently, cell culture media after incubation with SFN contained a metabolite able to inhibit HDAC enzymatic activity [169].”
BackgroundEpigenetics in cancer: Targeting chromatin modifications
Ellis, L., Atadja, P. W., & Johnstone, R. W. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0860 · Cited by 479 · cited 1×
“Chaetocin, a fungal metabolite, was one of the first identified selective inhibitors for the SUV39 class of HMTs targeting H3K9 (overview in [238]).”
BackgroundNF-κB addiction and its role in cancer: ‘one size does not fit all’
Chaturvedi, M. M., Sung, B., Yadav, V. R., Kannappan, R., & Aggarwal, B. B. (2011) · Oncogene · doi:10.1038/onc.2010.566 · Cited by 473
Pathological and molecular aspects of prostate cancer
DeMarzo, A. M., Nelson, W. G., Isaacs, W. B., & Epstein, J. I. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12779-1 · Cited by 472
Antitumor Activity of a Small-Molecule Inhibitor of Human Silent Information Regulator 2 Enzymes
Heltweg, B., Gatbonton, T., Schuler, A. D., Posakony, J., Li, H., Goehle, S., Kollipara, R., DePinho, R. A., Gu, Y., Simon, J. A., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3617 · Cited by 469 · cited 2×
“The b-naphthol compound cambinol was identified in a chemical screen and inhibits both SIRT1 and SIRT2, whereas class I and II HDACs were not affected [134].”
BackgroundTelomeric and extra-telomeric roles for telomerase and the telomere-binding proteins
Martínez, P., & Blasco, M. A. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3025 · Cited by 468 · cited 2×
“Sequence variations at the hTERT locus on chromosome 5 have been associated with many types of cancer, including acute myelogenous leukemia and tumors of the lung, bladder, prostate, cervix, and pancreas (review in [275]).”
BackgroundDietary Polyphenols May Affect DNA Methylation
Fang, M., Chen, D., & Yang, C. S. (2007) · The Journal of Nutrition · doi:10.1093/jn/137.1.223s · Cited by 462 · cited 3×
“reported demethylation and re-expression of p16 in KYSE510 esophageal cancer cells and HCT116 colon cancer cells after treatment with EGCG [37, 55].”
BackgroundPhenotypic differences in genetically identical organisms: the epigenetic perspective
Wong, A. H. C., Gottesman, I. I., & Petronis, A. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi116 · Cited by 431 · cited 1×
“) [3, 9] as has been exemplified in studies with monozygotic twins and inbred animals [10, 11].”
ResultHow does SIRT1 affect metabolism, senescence and cancer?
Brooks, C. L., & Gu, W. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2562 · Cited by 428 · cited 2×
“p53 activity is also epigenetically controlled: deacetylation of p53 through SIRT1 (silent information regulator 1), a member of the sirtuin HDAC class III family, prevents p53-mediated transactivation of cell cycle inhibitor p21 and pro-apoptotic Bax, allowing promotion of cell survival after DNA damage and ultimatel…”
BackgroundFang, M. Z., Chen, D., Sun, Y., Jin, Z., Christman, J. K., & Yang, C. S. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0406 · Cited by 410 · cited 3×
“Similar effects were observed with genistein in the same cell line [78].”
BackgroundResultThe RASSF1A Tumor Suppressor Blocks Cell Cycle Progression and Inhibits Cyclin D1 Accumulation
Shivakumar, L., Minna, J., Sakamaki, T., Pestell, R., & White, M. A. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.12.4309-4318.2002 · Cited by 393 · cited 1×
“Overexpression of RassF1A in vitro was found to inhibit accumulation of cyclin D1, thereby blocking G1/S cell cycle progression [242].”
BackgroundRole of the Ras-Association Domain Family 1 Tumor Suppressor Gene in Human Cancers
Agathanggelou, A., Cooper, W. N., & Latif, F. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4088 · Cited by 388 · cited 2×
“RassF1A is involved in two pathways commonly deregulated in cancer – cell cycle regulation and apoptosis [239, 240].”
BackgroundFunctional Diversity of DNA Methyltransferase Inhibitors in Human Cancer Cell Lines
Stresemann, C., Brueckner, B., Musch, T., Stopper, H., & Lyko, F. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2821 · Cited by 385
Nutrition, epigenetics, and developmental plasticity: implications for understanding human disease
Burdge, G. C., & Lillycrop, K. A. (2010) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.012809.104751 · Cited by 372
Lee, W. J., & Zhu, B. T. (2006) · Carcinogenesis · doi:10.1093/carcin/bgi206 · Cited by 372
Sulforaphane Causes Epigenetic Repression of hTERT Expression in Human Breast Cancer Cell Lines
Meeran, S. M., Patel, S. N., & Tollefsbol, T. O. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011457 · Cited by 370 · cited 1×
“In addition, SFN treatment inhibited HDAC activity and may modulated histone methylation by increased expression of the histone demethylase RBP2 [173, 178].”
BackgroundNandakumar, V., Vaid, M., & Katiyar, S. K. (2011) · Carcinogenesis · doi:10.1093/carcin/bgq285 · Cited by 368
Molecular Targets of Dietary Phenethyl Isothiocyanate and Sulforaphane for Cancer Chemoprevention
Cheung, K. L., & Kong, A.-N. (2010) · The AAPS Journal · doi:10.1208/s12248-009-9162-8 · Cited by 364
Epigenetic changes induced by curcumin and other natural compounds
Reuter, S., Gupta, S. C., Park, B., Goel, A., & Aggarwal, B. B. (2011) · Genes & Nutrition · doi:10.1007/s12263-011-0222-1 · Cited by 362 · cited 1×
“The available information on the topic has been summarized in several recent review articles [20–36, 121, 122, 203, 204].”
BackgroundChoi, K.-C., Jung, M. G., Lee, Y.-H., Yoon, J. C., Kwon, S. H., Kang, H.-B., Kim, M.-J., Cha, J.-H., Kim, Y. J., Jun, W. J., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2442 · Cited by 354 · cited 1×
“Inhibition of p65 acetylation reduced EBV-induced B-lymphocyte transformation [147].”
BackgroundChemopreventive effects of natural dietary compounds on cancer development
Pan, M.-H., & Ho, C.-T. (2008) · Chemical Society Reviews · doi:10.1039/b801558a · Cited by 346
Sulforaphane inhibits histone deacetylase in vivo and suppresses tumorigenesis in Apc min mice
Myzak, M. C., Dashwood, W. M., Orner, G. A., Ho, E., & Dashwood, R. H. (2006) · The FASEB Journal · doi:10.1096/fj.05-4785fje · Cited by 344 · cited 2×
“In APCmice, SFN treatment reduced tumor multiplicity, increased ac-H3 levels, and ac-H3 occupancy at the p21 and Bax promoter in tumor samples, and induced expression of pro-apoptotic Bax [176].”
BackgroundDiet induced epigenetic changes and their implications for health: Nutrition, epigenetics and health
McKay, J. A., & Mathers, J. C. (2011) · Acta Physiologica · doi:10.1111/j.1748-1716.2011.02278.x · Cited by 338
Sulforaphane induces cell type–specific apoptosis in human breast cancer cell lines
Pledgie-Tracy, A., Sobolewski, M. D., & Davidson, N. E. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0494 · Cited by 335
Regulatory Mechanisms of Tumor Suppressor P16INK4Aand Their Relevance to Cancer
Li, J., Poi, M. J., & Tsai, M.-D. (2011) · Biochemistry · doi:10.1021/bi200642e · Cited by 334 · cited 2×
“p16 (inhibitor of Cdk4, also known as CDKN2, CDK inhibitor 2) is genetically inactivated by point mutations, deletion, or DNA methylation in about 50% of all human cancers [214].”
BackgroundCurcumin is a potent DNA hypomethylation agent
Liu, Z., Xie, Z., Jones, W., Pavlovicz, R. E., Liu, S., Yu, J., Li, P.-K., Lin, J., Fuchs, J. R., Marcucci, G., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.12.041 · Cited by 330
Myzak, M. C., Tong, P. S. L., Dashwood, W., Dashwood, R. H., & Ho, E. (2007) · PubMed · doi:10.3181/00379727-207-2320227 · Cited by 313 · cited 1×
“prostate tissue and in xenografts [177].”
Exploring and explaining epigenetic effects
Henikoff, S., & Matzke, M. A. (1997) · Trends in Genetics · doi:10.1016/s0168-9525(97)01219-5 · Cited by 307 · cited 10×
“(P H I) S y n th et ic # ro m o te r m et h M y el o m a p 6 [1 0 2 ]”
BackgroundInfluentialMyzak, M. C., Hardin, K., Wang, R., Dashwood, R. H., & Ho, E. (2006) · Carcinogenesis · doi:10.1093/carcin/bgi265 · Cited by 306 · cited 2×
“Further studies confirmed the HDAC inhibitory activity of SFN intervention in various human cancer cell lines [169, 170, 174].”
BackgroundFüllgrabe, J., Kavanagh, E., & Joseph, B. (2011) · Oncogene · doi:10.1038/onc.2011.121 · Cited by 304 · cited 2×
“Histones can be modified through sequence-specific transcription factors or on a more global scale through histone-modifying enzymes [120].”
BackgroundDietary histone deacetylase inhibitors: From cells to mice to man
DASHWOOD, R., & HO, E. (2007) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2007.04.001 · Cited by 296 · cited 2×
“In addition, SFN treatment inhibited HDAC activity and may modulated histone methylation by increased expression of the histone demethylase RBP2 [173, 178].”
BackgroundHuang, Y., Greene, E., Murray Stewart, T., Goodwin, A. C., Baylin, S. B., Woster, P. M., & Casero, R. A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700720104 · Cited by 292 · cited 2×
“Treatment of colon cancer cells with polyamine analogs indeed resulted in re-expression sFRP1, sFRP4, sFRP5s, and transcription factor GATA5 [186].”
BackgroundFolate and cancer: how DNA damage, repair and methylation impact on colon carcinogenesis
Duthie, S. J. (2011) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-010-9128-0 · Cited by 289 · cited 2×
“Overall, the results are inconclusive and depend on various parameters, for example dose and timing of the intervention, the severity of folate deficiency, and health status (reviewed in [23, 66–68, 76]).”
BackgroundCancer Chemopreventive Potential of Apples, Apple Juice, and Apple Components
Gerhauser, C. (2008) · Planta Medica · doi:10.1055/s-0028-1088300 · Cited by 288
Curcumin-induced histone hypoacetylation: The role of reactive oxygen species
Kang, J., Chen, J., Shi, Y., Jia, J., & Zhang, Y. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.01.014 · Cited by 286
Chen, L.-F., & Greene, W. C. (2003) · Journal of Molecular Medicine · doi:10.1007/s00109-003-0469-0 · Cited by 275 · cited 1×
“Reversible acetylation at lysine 310 mediated by the HAT p300 is required for full trans-activating activity [260–262].”
BackgroundLinhart, H. G., Lin, H., Yamada, Y., Moran, E., Steine, E. J., Gokhale, S., Lo, G., Cantu, E., Ehrich, M., He, T., et al. (2007) · Genes & Development · doi:10.1101/gad.1594007 · Cited by 274
Han, J. W., Ahn, S. H., Park, S. H., Wang, S. Y., Bae, G., Seo, D. W., Kwon, H. K., Hong, S., Lee, H. Y., Lee, Y., et al. (2000) · PubMed · Cited by 273
Nakata, S., Yoshida, T., Horinaka, M., Shiraishi, T., Wakada, M., & Sakai, T. (2004) · Oncogene · doi:10.1038/sj.onc.1207830 · Cited by 271
Kim, Y.-I. (2005) · The Journal of Nutrition · doi:10.1093/jn/135.11.2703 · Cited by 265 · cited 1×
“Overall, the results are inconclusive and depend on various parameters, for example dose and timing of the intervention, the severity of folate deficiency, and health status (reviewed in [23, 66–68, 76]).”
BackgroundSung, B., Pandey, M. K., Ahn, K. S., Yi, T., Chaturvedi, M. M., Liu, M., & Aggarwal, B. B. (2008) · Blood · doi:10.1182/blood-2007-10-117994 · Cited by 264
Davis, C. D., Uthus, E. O., & Finley, J. W. (2000) · The Journal of Nutrition · doi:10.1093/jn/130.12.2903 · Cited by 261
Epigenetic lesions causing genetic lesions in human cancer
Esteller, M. (2000) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00303-8 · Cited by 258 · cited 1×
“Loss of hMLH1 expression by germ-line mutations and promoter hypermethylation leads to microsatellite instability that is mainly associated with hereditary non-polyposis colorectal cancer (HNPCC), but also observed in endometrial and gastric tumors [249].”
BackgroundGiudice, A., Arra, C., & Turco, M. C. (2010) · Methods in Molecular Biology · doi:10.1007/978-1-60761-738-9_3 · Cited by 256 · cited 2×
“As mentioned above, transcription factor Nrf2 (nuclear factor-erythroid 2 p45related factor 2) plays an important role in phase 2 enzyme induction [207].”
BackgroundSIRT1: recent lessons from mouse models
Herranz, D., & Serrano, M. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2962 · Cited by 255 · cited 1×
“However, despite the fact that SIRT1 can inactivate p53 and is upregulated in several human cancer types, recent data suggest that SIRT1 is a tumor suppressor in vivo [244].”
BackgroundImpact on DNA Methylation in Cancer Prevention and Therapy by Bioactive Dietary Components
Li, Y., & Tollefsbol, T. O. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710791299966 · Cited by 255 · cited 1×
“The available information on the topic has been summarized in several recent review articles [20–36, 121, 122, 203, 204].”
BackgroundEpigenetic targets of bioactive dietary components for cancer prevention and therapy
Meeran, S. M., Ahmed, A., & Tollefsbol, T. O. (2010) · Clinical Epigenetics · doi:10.1007/s13148-010-0011-5 · Cited by 255
Histone deacetylase inhibitors: Signalling towards p21cip1/waf1
Ocker, M., & Schneider-Stock, R. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.03.001 · Cited by 250 · cited 4×
“p21 was overexpressed after downregulation of DNMTs, but the mechanism of induction might be independent of changes in promoter methylation and rather involve competing interactions of DNMTs and p21 with PCNA and enhanced stability [224, 227].”
BackgroundInfluentialKhor, T. O., Huang, Y., Wu, T.-Y., Shu, L., Lee, J., & Kong, A.-N. T. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.07.065 · Cited by 245
Vanden Berghe, W. (2012) · Pharmacological Research · doi:10.1016/j.phrs.2012.03.007 · Cited by 243 · cited 1×
“The available information on the topic has been summarized in several recent review articles [20–36, 121, 122, 203, 204].”
BackgroundPadhye, S., Ahmad, A., Oswal, N., & Sarkar, F. H. (2009) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-2-38 · Cited by 239
Nutritional influences on epigenetics and age-related disease
Park, L. K., Friso, S., & Choi, S.-W. (2012) · Proceedings of the Nutrition Society · doi:10.1017/s0029665111003302 · Cited by 236
Sun, Y., Jiang, X., Chen, S., & Price, B. D. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.06.092 · Cited by 234
Nrf2 Expression Is Regulated by Epigenetic Mechanisms in Prostate Cancer of TRAMP Mice
Yu, S., Khor, T. O., Cheung, K.-L., Li, W., Wu, T.-Y., Huang, Y., Foster, B. A., Kan, Y. W., & Kong, A.-N. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008579 · Cited by 228
Modulation of gene methylation by genistein or lycopene in breast cancer cells
King‐Batoon, A., Leszczynska, J. M., & Klein, C. B. (2008) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20363 · Cited by 225 · cited 2×
“A single low dose of lycopene, a caroteinoid isolated from tomatoes, reduced RARb2 andHIN1 promoter methylation in immortalized MCF10A human breast cells, but not in MCF-7 breast cancer cells [79].”
BackgroundEpigenetic and genetic mechanisms contribute to telomerase inhibition by EGCG
Berletch, J. B., Liu, C., Love, W. K., Andrews, L. G., Katiyar, S. K., & Tollefsbol, T. O. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21417 · Cited by 218
Pandey, M., Shukla, S., & Gupta, S. (2010) · International Journal of Cancer · doi:10.1002/ijc.24988 · Cited by 218 · cited 1×
“Transcription was facilitated by enhanced binding of transcription factor Sp1 to the GSTP1 promoter [45].”
BackgroundTumor Susceptibility of Rassf1a Knockout Mice
Tommasi, S., Dammann, R., Zhang, Z., Wang, Y., Liu, L., Tsark, W. M., Wilczynski, S. P., Li, J., You, M., & Pfeifer, G. P. (2005) · Cancer Research · doi:10.1158/0008-5472.92.65.1 · Cited by 214 · cited 2×
“Incubation of colon cancer cell lines with apple polyphenols also led to reexpression of hMLH1 by promoter hypomethylation due to reduced DNMT1 andDNMT3b protein expression [241].”
BackgroundEpigenetic targets in hematopoietic malignancies
Claus, R., & Lübbert, M. (2003) · Oncogene · doi:10.1038/sj.onc.1206814 · Cited by 214 · cited 2×
“In comparison to other tumor suppressor genes, methylation at the p21 promoter was not frequently observed in hematological malignancies [226].”
BackgroundMajid, S., Dar, A. A., Ahmad, A. E., Hirata, H., Kawakami, K., Shahryari, V., Saini, S., Tanaka, Y., Dahiya, A. V., Khatri, G., et al. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp042 · Cited by 214
Kim, K.-C., Friso, S., & Choi, S.-W. (2009) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2009.06.008 · Cited by 211
Chuang, J. C., Yoo, C. B., Kwan, J. M., Li, T. W. H., Liang, G., Yang, A. S., & Jones, P. A. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0172 · Cited by 210
Majid, S., Kikuno, N., Nelles, J., Noonan, E., Tanaka, Y., Kawamoto, K., Hirata, H., Li, L. C., Zhao, H., Okino, S. T., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2290 · Cited by 209 · cited 1×
“This resulted in hyperacetylation of histones H3 and H4, increased association of acetylated H3K4 with the transcription start sites of p16 and p21, re-expression of p16 and p21, and cell cycle arrest [153].”
BackgroundGenistein Alters Methylation Patterns in Mice
Day, J. K., Bauer, A. M., desBordes, C., Zhuang, Y., Kim, B.-E., Newton, L. G., Nehra, V., Forsee, K. M., MacDonald, R. S., Besch-Williford, C., et al. (2002) · The Journal of Nutrition · doi:10.1093/jn/132.8.2419s · Cited by 203
Stefanska, B., Karlic, H., Varga, F., Fabianowska‐Majewska, K., & Haslberger, A. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02002.x · Cited by 200 · cited 1×
“The available information on the topic has been summarized in several recent review articles [20–36, 121, 122, 203, 204].”
BackgroundFolate, colorectal carcinogenesis, and DNA methylation: Lessons from animal studies
Kim, Y. (2004) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20025 · Cited by 200 · cited 1×
“Overall, the results are inconclusive and depend on various parameters, for example dose and timing of the intervention, the severity of folate deficiency, and health status (reviewed in [23, 66–68, 76]).”
BackgroundPaluszczak, J., Krajka-Kuźniak, V., & Baer-Dubowska, W. (2010) · Toxicology Letters · doi:10.1016/j.toxlet.2009.10.010 · Cited by 199 · cited 1×
“activity in vitro by 20–88% [40].”
Li, Y., Yuan, Y.-Y., Meeran, S. M., & Tollefsbol, T. O. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-274 · Cited by 199
The tumor suppressor RASSF1A in human carcinogenesis: an update.
Dammann, R., Schagdarsurengin, U., Seidel, C., Strunnikova, M., Rastetter, M., Baier, K., & Pfeifer, G. P. (2005) · PubMed · doi:10.14670/hh-20.645 · Cited by 197 · cited 3×
“RassF1A is involved in two pathways commonly deregulated in cancer – cell cycle regulation and apoptosis [239, 240].”
BackgroundGSTP1 CpG island hypermethylation as a molecular biomarker for prostate cancer
Nakayama, M., Gonzalgo, M. L., Yegnasubramanian, S., Lin, X., De Marzo, A. M., & Nelson, W. G. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10740 · Cited by 197 · cited 3×
“In addition to prostate cancer, GSTP1 hypermethylation is frequent in ~30% and >80% of breast cancer and hepatocellular carcinoma, respectively [209].”
BackgroundInfluentialGenistein depletes telomerase activity through cross‐talk between genetic and epigenetic mechanisms
Li, Y., Liu, L., Andrews, L. G., & Tollefsbol, T. O. (2009) · International Journal of Cancer · doi:10.1002/ijc.24398 · Cited by 194
Huang, Y., Stewart, T. M., Wu, Y., Baylin, S. B., Marton, L. J., Perkins, B., Jones, R. J., Woster, P. M., & Casero, R. A. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1293 · Cited by 194 · cited 2×
“which demethylates mono-methylated and di-methylated H3K4 as part of a multiprotein co-repressor complex and thereby broadly represses gene expression ([187] and references cited therein).”
BackgroundDisulfiram is a DNA demethylating agent and inhibits prostate cancer cell growth
Lin, J., Haffner, M. C., Zhang, Y., Lee, B. H., Brennen, W. N., Britton, J., Kachhap, S. K., Shim, J. S., Liu, J. O., Nelson, W. G., et al. (2011) · The Prostate · doi:10.1002/pros.21247 · Cited by 194
Nian, H., Delage, B., Ho, E., & Dashwood, R. H. (2009) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20454 · Cited by 193 · cited 2×
“Both compounds are further metabolized to allyl mercaptan (AM) and other metabolites (reviewed in [121]).”
BackgroundLi, Y., Kong, D., Wang, Z., & Sarkar, F. H. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0105-y · Cited by 190 · cited 1×
“The available information on the topic has been summarized in several recent review articles [20–36, 121, 122, 203, 204].”
BackgroundKai, L., Samuel, S. K., & Levenson, A. S. (2010) · International Journal of Cancer · doi:10.1002/ijc.24928 · Cited by 187 · cited 2×
“These combination effects might present an innovative therapeutic strategy for the management of prostate cancer [165].”
BackgroundChen, Y., Shu, W., Chen, W., Wu, Q., Liu, H., & Cui, G. (2007) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2007.00142.x · Cited by 187 · cited 1×
“Reduction was prevented by co-treatment with MG-132, an inhibitor of the 26S proteasome [136].”
BackgroundShu, L., Khor, T. O., Lee, J.-H., Boyanapalli, S. S. S., Huang, Y., Wu, T.-Y., Saw, C. L.-L., Cheung, K.-L., & Kong, A.-N. T. (2011) · The AAPS Journal · doi:10.1208/s12248-011-9300-y · Cited by 187
Kato, K., Long, N. K., Makita, H., Toida, M., Yamashita, T., Hatakeyama, D., Hara, A., Mori, H., & Shibata, T. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604521 · Cited by 183
Sirchia, S. M., Ren, M., Пили, Р., Sironi, E., Somenzi, G., Ghidoni, R., Toma, S., Nicolò, G., & Sacchi, N. (2002) · PubMed · Cited by 182
Clarke, J. D., Hsu, A., Yu, Z., Dashwood, R. H., & Ho, E. (2011) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201000547 · Cited by 177
Xiang, N., Zhao, R., Song, G., & Zhong, W. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn179 · Cited by 174 · cited 1×
“Incubation with low dose sodium selenite lowered DNMT1 mRNA and protein expression, reduced global DNA methylation, and led to the reexpression of GSTP1 associated with reduced GSTP1 promoter methylation [115].”
BackgroundGibbs, A., Schwartzman, J., Deng, V., & Alumkal, J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908908106 · Cited by 172 · cited 1×
“Therefore, similar to genistein [152], SFN may act as a prostate cancer preventive agent by affecting the complex of HSP90-AR through HDAC6 inhibition [171].”
BackgroundDevelopment of curcumin as an epigenetic agent
Fu, S., & Kurzrock, R. (2010) · Cancer · doi:10.1002/cncr.25414 · Cited by 170 · cited 1×
“They are organized into four families based on structure homology [189] and often possess distinct histone specificity.”
BackgroundCancer Chemoprevention by Targeting the Epigenome
Huang, J., Plass, C., & Gerhauser, C. (2011) · Current Drug Targets · doi:10.2174/138945011798184155 · Cited by 169 · cited 2×
“The available information on the topic has been summarized in several recent review articles [20–36, 121, 122, 203, 204].”
BackgroundChoi, K.-C., Lee, Y.-H., Jung, M. G., Kwon, S. H., Kim, M.-J., Jun, W. J., Lee, J., Lee, J. M., & Yoon, H.-G. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0239 · Cited by 166 · cited 2×
“Inhibition of p65 acetylation was also confirmed in vivo in macrophages of LPS-stimulated mice [149].”
BackgroundEpigenetic drivers and genetic passengers on the road to cancer
Sawan, C., Vaissière, T., Murr, R., & Herceg, Z. (2008) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2008.03.002 · Cited by 166 · cited 1×
“It has been suggested that silencing of MGMT is associated with 72% of the mutations observed in the p53 gene, and with 40% of the colon cancer cases induced through K-ras mutations [250].”
BackgroundCurcumin-induced HDAC inhibition and attenuation of medulloblastoma growth in vitro and in vivo
Lee, S. J., Krauthauser, C., Maduskuie, V., Fawcett, P. T., Olson, J. M., & Rajasekaran, S. A. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-144 · Cited by 166
Qiu, J. (2006) · Nature · doi:10.1038/441143a · Cited by 166 · cited 10×
“# ro m o te r m et h L eu k em ia p 3 p at h w ay [5 2 ]”
BackgroundInfluentialWang, L.-S., Arnold, M., Huang, Y.-W., Sardo, C., Seguin, C., Martin, E., Huang, T. H.-M., Riedl, K., Schwartz, S., Frankel, W., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1260 · Cited by 165 · cited 3×
“Overall, demethylation of Wnt inhibitors led to reduced expression of b-catenin, E-cadherin, and Ki67 as a proliferation marker in tumor tissue, and induced apoptosis [41].”
BackgroundAn Essential Role for DNA Methyltransferase DNMT3B in Cancer Cell Survival
Beaulieu, N., Morin, S., Chute, I. C., Robert, M.-F., Nguyen, H., & MacLeod, A. R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204734200 · Cited by 163 · cited 2×
“Consistently, depletion of DNMT3b was shown previously to cause RASSF1A reactivation, cell growth inhibition, and apoptosis induction in cancer cell lines, but not in normal cells [14].”
BackgroundTang, W.-Y., Newbold, R., Mardilovich, K., Jefferson, W., Cheng, R. Y. S., Medvedovic, M., & Ho, S.-M. (2008) · Endocrinology · doi:10.1210/en.2008-0682 · Cited by 162
Myzak, M., & Dashwood, R. (2006) · Current Drug Targets · doi:10.2174/138945006776359467 · Cited by 160
Papoutsis, A. J., Lamore, S. D., Wondrak, G. T., Selmin, O. I., & Romagnolo, D. F. (2010) · Journal of Nutrition · doi:10.3945/jn.110.123422 · Cited by 160
Davis, C. D., & Uthus, E. O. (2003) · The Journal of Nutrition · doi:10.1093/jn/133.9.2907 · Cited by 160
Histone deacetylases: target enzymes for cancer therapy
Mottet, D., & Castronovo, V. (2007) · Clinical & Experimental Metastasis · doi:10.1007/s10585-007-9131-5 · Cited by 158 · cited 2×
“Class III is comprised of sirtuins 1–7, which are structurally unrelated to class I and II HDACs and require NAD as a cofactor for activity [191, 192].”
BackgroundMGMT hypermethylation: A prognostic foe, a predictive friend
Jacinto, F. V., & Esteller, M. (2007) · DNA Repair · doi:10.1016/j.dnarep.2007.03.013 · Cited by 158
Modulation of DNA Methylation by a Sesquiterpene Lactone Parthenolide
Liu, Z., Liu, S., Xie, Z., Pavlovicz, R. E., Wu, J., Chen, P., Aimiuwu, J., Pang, J., Bhasin, D. K., Neviani, P., et al. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.147934 · Cited by 157
Wang, L. G., Beklemisheva, A. A., Liu, X. M., Ferrari, A. C., Feng, J. Q., & Chiao, J.-W. (2006) · Molecular Carcinogenesis · doi:10.1002/mc.20258 · Cited by 155 · cited 1×
“Reduced DNA methylation at specific CpG sites was associated with enhanced protein expression and increased GSTP1 enzymatic activity [100].”
BackgroundDietary Manipulation of Histone Structure and Function
Delage, B., & Dashwood, R. H. (2008) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.28.061807.155354 · Cited by 155
Mutator pathways unleashed by epigenetic silencing in human cancer
Jacinto, F. V., & Esteller, M. (2007) · Mutagenesis · doi:10.1093/mutage/gem009 · Cited by 151 · cited 1×
“Cancer genomes are characterized by accumulation of genomic instability and chromosomal aberrations, associated with underlying defects in the DNA repair machinery [248].”
BackgroundHistone methyltransferases, diet nutrients and tumour suppressors
Huang, S. (2002) · Nature reviews. Cancer · doi:10.1038/nrc819 · Cited by 151 · cited 1×
“Epidemiological studies have indicated that low folate levels are associated with an increased risk for colorectum, breast, ovary, pancreas, brain, lung, and cervix cancer [66, 76, 205].”
BackgroundNature or nurture: Let food be your epigenetic medicine in chronic inflammatory disorders
Szic, K. S. V., Ndlovu, ’. N., Haegeman, G., & Berghe, W. V. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.07.029 · Cited by 149 · cited 1×
“The available information on the topic has been summarized in several recent review articles [20–36, 121, 122, 203, 204].”
BackgroundMeeran, S. M., Patel, S. N., Chan, T.-H., & Tollefsbol, T. O. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0009 · Cited by 146
Gene silencing by DNA methylation in haematological malignancies
Boultwood, J., & Wainscoat, J. S. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06604.x · Cited by 145 · cited 1×
“Hypermethylation of the p16 promoter is frequently observed in all major human malignancies, including hepatocellular carcinoma, primary gastric carcinoma, Barrett’s esophagus and esophageal adenocarcinoma [214], breast cancer [215], squamous cell carcinoma of the lung [216], colorectal cancer [217], lymphoma [218], a…”
BackgroundNian, H., Delage, B., Pinto, J. T., & Dashwood, R. H. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn165 · Cited by 139
Qin, W., Zhu, W., Shi, H., Hewett, J. E., Ruhlen, R. L., MacDonald, R. S., Rottinghaus, G. E., Chen, Y.-C., & Sauter, E. R. (2009) · Nutrition and Cancer · doi:10.1080/01635580802404196 · Cited by 138 · cited 2×
“The low dose of isoflavones further reduced methylation, whereas the high dose weakly increased methylation levels of both genes [92].”
BackgroundShima, K., Nosho, K., Baba, Y., Cantor, M., Meyerhardt, J. A., Giovannucci, E. L., Fuchs, C. S., & Ogino, S. (2011) · International Journal of Cancer · doi:10.1002/ijc.25432 · Cited by 137 · cited 1×
“Hypermethylation of the p16 promoter is frequently observed in all major human malignancies, including hepatocellular carcinoma, primary gastric carcinoma, Barrett’s esophagus and esophageal adenocarcinoma [214], breast cancer [215], squamous cell carcinoma of the lung [216], colorectal cancer [217], lymphoma [218], a…”
BackgroundThe role of histone acetylation in age-associated memory impairment and Alzheimer’s disease
Stilling, R. M., & Fischer, A. (2011) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2011.04.002 · Cited by 136
Cancer epigenetics: above and beyond
Brait, M., & Sidransky, D. (2011) · Toxicology Mechanisms and Methods · doi:10.3109/15376516.2011.562671 · Cited by 135 · cited 2×
“Major mechanisms of miRNA deregulation include genetic and epigenetic alterations as well as defects in the miRNA processing machinery [196].”
BackgroundHistone acetyltransferases are crucial regulators in NF-κB mediated inflammation
Ghizzoni, M., Haisma, H. J., Maarsingh, H., & Dekker, F. J. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.03.009 · Cited by 134
McCabe, M. T., Low, J. A., Daignault, S., Imperiale, M. J., Wojno, K. J., & Day, M. L. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2020 · Cited by 134 · cited 1×
“In tumor tissue, MGMT promoter methylation was reduced by 5-Aza treatment, and MGMT mRNA expression was induced [254].”
BackgroundLysine methylation regulates the pRb tumour suppressor protein
Munro, S., Khaire, N., Inche, A. G., Carr, S. M., & Thangue, N. B. L. (2010) · Oncogene · doi:10.1038/onc.2009.511 · Cited by 133 · cited 1×
“Similar to lysine acetylation, lysine methylation is not limited to histone proteins, and several non-histone protein substrates including p53, retinoblastoma protein (RB), the NF-kB subunit RelA, and estrogen receptor a (ERa) have been identified (summarized in [198–200]).”
BackgroundThe Epigenome as a Target for Cancer Chemoprevention
Kopelovich, L., Crowell, J. A., & Fay, J. R. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dig109 · Cited by 133 · cited 1×
“Increased methylation (DNA hypermethylation) of promoter CGIs leads to transcriptional silencing of tumor suppressors and other genes with important biological functions [12, 16, 17].”
BackgroundGenistein down-regulates androgen receptor by modulating HDAC6-Hsp90 chaperone function
Basak, S., Pookot, D., Noonan, E. J., & Dahiya, R. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0617 · Cited by 132 · cited 2×
“These data indicate that prostate cancer preventive potential of genistein may be mediated through modulating the complex of HDAC6 with HSP90 and AR [152].”
BackgroundPhytochemical Antioxidants Modulate Mammalian Cellular Epigenome: Implications in Health and Disease
Malireddy, S., Kotha, S. R., Secor, J. D., Gurney, T. O., Abbott, J. L., Maulik, G., Maddipati, K. R., & Parinandi, N. L. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4600 · Cited by 129 · cited 1×
“The available information on the topic has been summarized in several recent review articles [20–36, 121, 122, 203, 204].”
BackgroundDietary omega-3 polyunsaturated fatty acids suppress expression of EZH2 in breast cancer cells
Dimri, M., Bommi, P. V., Sahasrabuddhe, A. A., Khandekar, J. D., & Dimri, G. P. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp305 · Cited by 129
Khan, S. I., Aumsuwan, P., Khan, I. A., Walker, L., & Dasmahapatra, A. K. (2011) · Chemical Research in Toxicology · doi:10.1021/tx200378c · Cited by 124 · cited 1×
“The available information on the topic has been summarized in several recent review articles [20–36, 121, 122, 203, 204].”
BackgroundRajendran, P., Delage, B., Dashwood, W. M., Yu, T.-W., Wuth, B., Williams, D. E., Ho, E., & Dashwood, R. H. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-68 · Cited by 124
Vardi, A., Bosviel, R., Rabiau, N., Adjakly, M., Satih, S., Dechelotte, P., Boiteux, J., Fontana, L., Bignon, Y., Guy, L., et al. (2010) · PubMed · Cited by 123
Promoter demethylation of WIF-1 by epigallocatechin-3-gallate in lung cancer cells.
Gao, Z., Xu, Z., Hung, M., Lin, Y., Wang, T., Gong, M., Zhi, X., Jablon, D. M., & You, L. (2009) · PubMed · Cited by 123
Regulatory functions of glutathione S-transferase P1-1 unrelated to detoxification
Tew, K. D., & Townsend, D. M. (2011) · Drug Metabolism Reviews · doi:10.3109/03602532.2011.552912 · Cited by 122 · cited 1×
“Recently, GSTP1 activity has also been associated with cell-signaling functions critical for survival, for example the regulation of c-Jun N-terminal kinase (JNK) activity and modulation of protein functions by S-glutathionylation [208].”
BackgroundChoudhury, S. R., Balasubramanian, S., Chew, Y. C., Han, B., Marquez, V. E., & Eckert, R. L. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr171 · Cited by 122
Death‐associated protein kinase (DAPK) and signal transduction: regulation in cancer
Michie, A. M., McCaig, A. M., Nakagawa, R., & Vukovic, M. (2010) · The FEBS Journal · doi:10.1111/j.1742-4658.2009.07414.x · Cited by 121 · cited 4×
“Death-associated protein kinase (DAPK) is a pro-apoptotic serine/threonine kinase acting in the extrinsic death receptor-mediated pathway of apoptosis induction [233, 247].”
BackgroundInfluentialGopal, Y. N. V., Arora, T. S., & Dyke, M. W. V. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2007.06.007 · Cited by 120 · cited 1×
“However, the exact mechanism how parthenolide induces HDAC1 degradation via ATM is presently unknown [157].”
BackgroundHua, W., Fu, Y.-S., Liao, Y.-J., Xia, W.-J., Chen, Y., Zeng, Y.-X., Kung, H., & Xie, D. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.03.051 · Cited by 119
Stefañska, B., Salamé, P., Bednarek, A. K., & Fabianowska‐Majewska, K. (2011) · British Journal Of Nutrition · doi:10.1017/s0007114511003631 · Cited by 119 · cited 2×
“analyzed whether PTEN silencing could be reversed in these cell lines after incubation with the chemopreventive agents all-trans-retinoic acid (ATRA), Vitamin D3, and resveratrol alone and in combination with nucleoside analogs such as 2-chloro-20-deoxyadenosine (2CdA), 9-b-D-arabinosyl-2-fluoroadenine (F-ara-A), and…”
BackgroundWang, L. G. (1992) · International Journal of Oncology · doi:10.3892/ijo_00000018 · Cited by 118 · cited 1×
“Exposure of prostate cancer cells to PEITC significantly enhanced histone acetylation, cell cycle arrest, and p53-independent up-regulation of CKIs, including p21 and p27 [158].”
BackgroundMechanism of p300 Specific Histone Acetyltransferase Inhibition by Small Molecules
Arif, M., Pradhan, S. K., G R, T., Vedamurthy, B. M., Agrawal, S., Dasgupta, D., & Kundu, T. K. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm800657z · Cited by 118
Epigenetic modifications and human pathologies: cancer and CVD
Duthie, S. J. (2011) · Proceedings of the Nutrition Society · doi:10.1017/s0029665110003952 · Cited by 116
Association between Folate Levels and CpG Island Hypermethylation in Normal Colorectal Mucosa
Wallace, K., Grau, M. V., Levine, A. J., Shen, L., Hamdan, R., Chen, X., Gui, J., Haile, R. W., Barry, E. L., Ahnen, D., et al. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0047 · Cited by 116
Li, Y., Li, X., & Guo, B. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-1924 · Cited by 116
p21WAF1 gene promoter is epigenetically silenced by CTIP2 and SUV39H1
Cherrier, T., Suzanne, S., Redel, L., Calao, M., Marban, C., Samah, B., Mukerjee, R., Schwartz, C., Gras, G., Sawaya, B. E., et al. (2009) · Oncogene · doi:10.1038/onc.2009.193 · Cited by 115 · cited 2×
“Alternatively, p21 expression can be transcriptionally silenced through recruitment of CTIP2 (COUP-TF-interacting protein 2) and interactions with HDACs and histone methyltransferases (HMTs) [180].”
BackgroundSeong, A., Yoo, J., Choi, K., Lee, M.-H., Lee, Y., Lee, J., Jun, W., Kim, S., & Yoon, H. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.06.029 · Cited by 114
Yuasa, Y., Nagasaki, H., Akiyama, Y., Hashimoto, Y., Takizawa, T., Kojima, K., Kawano, T., Sugihara, K., Imai, K., & Nakachi, K. (2008) · International Journal of Cancer · doi:10.1002/ijc.24231 · Cited by 114
Effects of histone acetylation and DNA methylation on p21WAF1regulation
Fang, J., & Lu, Y.-Y. (2002) · World Journal of Gastroenterology · doi:10.3748/wjg.v8.i3.400 · Cited by 112 · cited 1×
“p21 was overexpressed after downregulation of DNMTs, but the mechanism of induction might be independent of changes in promoter methylation and rather involve competing interactions of DNMTs and p21 with PCNA and enhanced stability [224, 227].”
BackgroundYoon, H.-G. (2012) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2012.966 · Cited by 112
Das, S., Foley, N., Bryan, K., Watters, K. M., Bray, I., Murphy, D. M., Buckley, P. G., & Stallings, R. L. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1534 · Cited by 111
Cited by
Influence of Metabolism on Epigenetics and Disease
Kaelin, W. G., & McKnight, S. L. (2013) · Cell · doi:10.1016/j.cell.2013.03.004 · Cited by 920
Cragg, G. M., & Pezzuto, J. M. (2016) · Medical Principles and Practice · doi:10.1159/000443404 · Cited by 798
Epigenetics across the human lifespan
Kanherkar, R. R., Bhatia-Dey, N., & Csoka, A. B. (2014) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2014.00049 · Cited by 407
Review of methods for analysis of carotenoids
Amorim-Carrilho, K. T., Cepeda, A., Fente, C., & Regal, P. (2014) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2013.12.011 · Cited by 315
Griffiths, K., Aggarwal, B., Singh, R., Buttar, H., Wilson, D., & De Meester, F. (2016) · Diseases · doi:10.3390/diseases4030028 · Cited by 293
Metadata
- Authors
- Gerhauser, C.
- Venue
- Topics in Current Chemistry
- Publisher
- Springer Berlin Heidelberg
- Published
- 2012
- Volume
- 329
- Pages
- 73-132
- ISSN
- 0340-1022 (ISSN-L)
- 1436-5049
- OpenAlex
- W110353796
- Cited by
- 194
- References
- 287
- Citations by year
- 2026: 5 · 2025: 3 · 2024: 8 · 2023: 7 · 2022: 9 · 2021: 9 · 2020: 8 · 2019: 16 · 2018: 10 · 2017: 19 · 2016: 21 · 2015: 32 · 2014: 19 · 2013: 26 · 2012: 2
- FWCI
- 43.32
- Type
- book chapter
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Topics in current chemistry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Nutrition, Genetics, and Disease
- Health Sciences › Medicine › Biochemistry (medical) › Phytochemicals and Antioxidant Activities
- Keywords
- chemoprevention, epigenetic modifications, DNA methylation, histone modifications, DNA methyltransferases, histone-modifying enzymes, micronutrients, folic acid, retinoic acid, selenium, butyrate, polyphenols, green tea, genistein, soy isoflavones, curcumin, resveratrol, isothiocyanates, cruciferous vegetables, indole-3-carbinol, diindolylmethane, sulforaphane, histone lysine methylation
- MeSH terms
- Animals, Cell Cycle, Cell Differentiation, Cell Division, DNA Repair, Histones, NF-kappa B, Apoptosis, DNA Methylation, MicroRNAs, Epigenesis, Genetic, Nutrigenomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.